EU expects to vaccinate majority by end of June, internal memo suggests

Eu Expects To Vaccinate Majority By End Of June, Internal Memo Suggests Eu Expects To Vaccinate Majority By End Of June, Internal Memo Suggests
Bloomberg News reported the news on Tuesday, citing an internal memo. Photo: Getty Images.
Share this article

Thomson Reuters

Most European Union states will have enough Covid-19 vaccines to immunise the majority of their people by the end of June, Bloomberg News reported on Tuesday, citing an internal memo.

Germany, France, Italy, Spain and the Netherlands will be in a position to fully inoculate more than 55 per cent of their populations by June end, the report added, citing projections in the memo by the EU executive, the European Commission.

The numbers confirm public estimates of vaccines the 27-nation bloc expects to receive in the second quarter.

The Commission has repeatedly said the EU, with a population of nearly 450 million, is to receive about 360 million doses by the end of June in addition to about 100 million already shipped.

That would be sufficient to meet its target of vaccinating at least 70 per cent of the bloc's adult population by the summer.


The bloc expects to receive in the April to June period 55 million doses of the single-dose vaccine developed by Johnson & Johnson, and another 300 million of two-dose shots from BioNTech-Pfizer, AstraZeneca and Moderna.

It is however unclear whether all expected doses will be delivered in line with timetables. The EU received about half of the expected doses in the first quarter because AstraZeneca made major cuts in its supplies to the EU then.

The new estimates already factor in a further major cut in AstraZeneca supplies in the second quarter.

The EU has coordinated the purchase of vaccines with EU governments but has no power on vaccination plans, which are run by EU states.

Rollouts depend on supplies but also on vaccination programmes, which have often been hampered in EU states because of safety and effectiveness concerns over the AstraZeneca vaccine.

The vaccine rollout picked up in the bloc at the end of March after a slow start.

Read More

Want us to email you top stories each lunch time?

Download our Apps
© 2023, developed by Square1 and powered by